Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07817875) titled 'Efficacy, Safety, and Pharmacokinetics of Tirzepatide (LY3298176) Once Weekly Versus Placebo in Pediatric Participants 6 to Less Than 12 Years of Age Who Have Obesity (ADVANCE-SURMOUNT-KIDS)' on Sept. 9.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).

Primary Sponsor: Eli Lilly and Company

Condition: Obesity

Intervention: Drug: Tirzepatide

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: September 2026

Target Sample Size: 150

Countries of Recruit...